Resources

Breathonix, a spin-off company from the National University of Singapore (NUS), has developed a rapid breath test that can detect the SARS-CoV-2 virus within a minute. A joint trial between Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai...

The Covid-19 pandemic has created both opportunities and obstacles for the medtech industry. Where those in the diagnostics space saw a window of opportunity open up, the cancellation of non-emergency procedures left many device developers in the lurch and suffering...

Roche has launched new SARS-CoV-2 research use only laboratory test to help monitor emerging mutations of coronavirus. The new cobas SARS-CoV-2 Variant Set 1 test can detect and differentiate the mutations found in SARS-CoV-2 variants including B.1.1.7, B.1.351 and...

The US Food and Drug Administration (FDA) is advising patients, caregivers and healthcare providers about the higher-than-expected risk of polyethylene component breakage in all Scandinavian Total Ankle Replacement (STAR Ankle) devices. STAR Ankle was originally...

Sandvik Materials Technology develops partnerships with OEMs all over the world to develop customised and optimised wire components specifically calibrated for their application. The company is divided into small and specialised units, including Business Unit Medical,...

FDA clears Baxter's connected, in-center dialysis machine chale Fri, 03/12/2021 - 10:08

Mitochondrial biotech Minovia Therapeutics nabs biopharma veteran Jacobs as new chief medical officer badams Fri, 03/12/2021 - 09:04

Monte Rosa snags $95M to speed lead 'molecular glue' treatment into the clinic aalidrus Fri, 03/12/2021 - 08:19

Prometheus upsizes IPO, fueling chase of Pfizer in bowel disease ntaylor Fri, 03/12/2021 - 07:34

UCSD spinout pursues gene therapy for chronic pain following positive data in mice aliu Fri, 03/12/2021 - 07:25

The legal basis for reprocessing under German law (MP Betreiber V) changes on May 26 2021 and will be replaced by medical remanufacturing in accordance with MDR. There are two options: 1) Medical remanufacturing with CE certification Legal basis is Article 17 (2) of...

Plastics offer very good properties, are often durable materials and are used in all possible areas – from packaging to the construction industry to medicine. If plastic products are circulated for as long as possible, the consumption of resources is reduced and the...

Plastics have become an indispensable part of our lives. By staying in the cycle for a long time, the products can minimize resource consumption. Many medical devices that have only been approved by the manufacturer for one-time use also contain plastics that can be...

Healthcare as an industry is particularly wasteful and toxic. A study, conducted by Fraunhofer Institute for Environmental, Safety, and Energy Technology UMSICHT, which was published in Sustainability, is the first comprehensive LCA exploring the environmental impact...

Many medical devices that have only been approved by the manufacturer for a single use contain plastics, for example electrophysiology catheters (cardiac catheters). A research team from the Fraunhofer Institute for Environmental, Safety and Energy Technology Umsicht...

“You did nothing wrong,” said the Department of Public Health contact tracer who called my spouse late on January 2nd, “you wore a mask and followed all the safety guidelines. We may never know ultimately how you got it.” The sentiment brought no relief – our whole...

2020 was an incredibly paradoxical year for those of us in biotech: the striking dichotomy of simultaneously experiencing agonizing tragedy alongside buoyant optimism. Read more. The post The Biotech Paradox of 2020: A Year In Review appeared first on Atlas Venture.

A look back at 2020 and to the future at Atlas Venture. View the newsletter. The post Atlas Venture’s 2020 Year in Review appeared first on Atlas Venture.

Novartis teamed up with Cadent Therapeutics on treatment-resistant depression back when the neuro-focused biotech was working under the radar. Five years later, the Swiss pharma is helping itself to the rest of Cadent’s pipeline in a deal worth $210 million upfront...

Five years after Novartis stepped up with a sizable deal that gave them worldwide rights to Surface Oncology’s lead cancer drug, GlaxoSmithKline is coming in at the other end of the pipeline, snagging a preclinical natural killer drug designed to whip up a more...

Over the course of my career in healthcare, I’ve been fortunate to serve in a leadership role through four IPOs and even more financing rounds. All told, I’ve raised well over $1.5 billion in capital. That means I’ve spent a lot of time thinking about dilution. By...